[Asia Economy Reporter Geum Boryeong] Samsung Biologics announced on the 16th that it will change its leadership from CEO Kim Tae-han to CEO Rim John Chongbo.



The reason for the change is the retirement of CEO Kim Tae-han.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing